Genetic analyses
Genomic DNA was isolated from peripheral blood using standard protocols. For mutation analysis of the DJ-1 gene, PCR reactions were performed in 25 or 50 µl containing 1x GibcoBRL PCR buffer, 1.5mM MgCl 2 , 0.01% W-1, 250µM of each dNTP, 0.4µM forward primer, 0.4µM reverse primer, 2.5 units of Taq DNA polymerase (GibcoBRL) and 50 ng genomic DNA/25 µl of PCR volume. For exon 2, the concentration of each primer was 2µM. For exon 1, DMSO 7% was used. Cycle conditions were: 5 min at 94°C; 35 cycles of 30 s denaturation at 94°C, 30 s annealing at temperatures reported below, and 90 s extension at 72°C; final extension 5 min at 72°C. Primers, annealing temperatures, and size of amplified fragments were as follows: Analysis of the genomic deletion found in the Dutch family. For sequencing purposes, a 1761 bp DNA fragment containing the deletion breakpoint was amplified using 2µM forward 5'-GCAAATAGCCAAAAGTGAAGTC-3' and 2µM reverse 5'-CGTACAAGACCTGCCAGGG-3' primers. PCR conditions were as above, with annealing temperatures of 70°→60° (-1°/cycle), then 60°, total 35 cycles. For testing the cosegregation in the Dutch family and the occurrence in population controls, a 2011 bp fragment containing the deletion breakpoint was amplified using 1µM forward 5'-GCAAATAGCCAAAAGTGAAGTC-3' and 1µM reverse 5'-TACTTTCAGCAGAATCATAAGG-3' primers; a 354 bp fragment containing exon 5 of DJ-1 gene was also amplified in the same PCR reaction using 0.2µM forward 5'-TGAGAAATGCCTTGCTTGGG-3' and 0.2µM reverse 5'-GCTATTTGGAATCAAACCATCG-3' primers. PCR conditions were as above, with annealing temperatures of 70°→60° (-1°/cycle), then 60°, total 35 cycles. Fragments were resolved using agarose 1.5% gel electrophoresis.
For RT-PCR analyses, lymphoblastoid cell lines were established from one patient of each PARK7-linked family and one unrelated normal control. Total mRNA was isolated, and cDNA was prepared according to standard protocols. The following primers (0. In some experiments, a 285 bp fragment of the KIAA833 cDNA was amplified as internal PCR control, using 0.4µM forward 5'-AGCTGCCGTCGTGCTGTAC-3' and 0.4µM reverse 5'-GGGTTGGTGCTTGCAATAAC-3' primers. PCR conditions were as above, with annealing temperatures of 66°→58° (-1°/cycle), then 58°, total 35 cycles.
For allele specific oligo (ASO) hybridization, PCR products containing DJ-1 exon 7 were blotted into Hybond-N+ membranes (Amersham Biosciences). The blots were hybridized for 1 hour at 37°C in 5X SSPE, 1% SDS and 0.05 mg/ml single strand salmon sperm DNA with either the normal or mutated sequence oligo. Filters were washed until a final stringency of 0.3 x SSC/0.1% SDS at 37°C. The following oligos were used for hybridization: wild-type allele TTTGCGCTTGCAATT, mutated allele (L166P) TTTGCGCCTGCAATT.
Northern blot analysis was performed according to manufacturers protocols (Clontech).
GenBank accession numbers:
DJ-1 genomic sequence: AL034417. DJ-1 transcripts: AB073864, AF021819, BC008188, D61380. DJ-1 protein: CAB52550, BAB71782, AAC12806, AAH08188, BAA09603.
Bioinformatics of DJ-1 protein
Multiple sequence alignments were produced with ClustalW (5) at the European Bioinformatics Institute (http://www2.ebi.ac.uk/clustalw). The phylogenetic tree of DJ-1 protein family was generated with TreeTop at GeneBee (6).
Molecular modeling of DJ-1 protein
Initial alignments for DJ-1 were obtained from the 3D-PSSM fold recognition server (7) which identified PDB entry 1G2I as the closest homolog of known structure. The alignment and also the model does not cover the N-terminal three and C-terminal 16 residues of DJ-1 protein. Side chains were built using WHAT IF (8) . The model was energy minimized with the YASARA NOVA force field which was shown to improve models (9) . Validation of the model with WHAT_CHECK (10) showed a Ramachandran Z-score of -2.46 and all other quality Z-scores about one standard deviation below the average high resolution X-ray structure, which is good for a model based on only 23% sequence identity.
DJ-1 expression vectors
Wild-type and mutant (L166P) DJ-1 cDNAs were cloned in pcDNA3.1/V5-His TOPO TA vector (Invitrogen) and checked by sequencing using the Big Dye Terminator ver. 3.0 chemistry (Applied Biosystems).
Cell culture and transfection COS cells were cultured in DMEM supplemented with 10% fetal calf serum, 100 units/ml penicillin and 100µg/ml streptomycin and were kept at 37°C in 5% CO 2 (all from GIBCO BRL). PC12 cells were grown in DMEM supplemented with 10% horse serum (Sigma) and 5% fetal calf serum, 100 units/ml penicillin and 100µg/ml streptomycin and kept at 37°C in 10% CO 2 . COS and PC12 cells were transiently transfected with the constructs mentioned above using the Lipofectamine + Reagent (Gibco) according to the manufacturer's recommendations. Transfected cells were fixed for immunofluorescence staining 24 and 48 h after transfection.
Immunofluorescence staining
Cells were rinsed with phosphate-buffered saline (PBS), fixed with 3% paraformaldehyde (10 min), permeabilized with methanol (15 min), blocked with PBS/5% bovine serum albumin /0.15% glycine (15 min) and incubated for 1h with monoclonal mouse anti-V5 antibody (Invitrogen), dilution 1:500. FITC-conjugated goat anti-mouse immunoglobulin G (1:500 1h) was used as secondary antibody (Sigma). Cells were mounted in Vectashield media (Vector) containing DAPI and examined with a Zeiss Axioplan 2 microscope equipped with digital camera. Mitochondrial staining was performed by using rhodamine-conjugated MitoTrack (1:2000) or by double-labeling immunofluorescence with rabbit anti-HSP60 antibody (1:200, 1h Stressgen) and TRITC-conjugated goat anti-rabbit immunoglobulin (1:500, 1h).
Supporting text
Clinical studies The Dutch and Italian PARK7-linked families have been described previously (11, 12) . The diagnosis of parkinsonism required the presence of two of three cardinal signs (resting tremor, bradykinesia, muscular rigidity), absence of atypical features (dementia early in disease course, ophtalmoplegia, pyramidal or cerebellar involvement), and no other identifiable causes. Brain imaging with computed tomography and/or magnetic resonance were unremarkable. Response to levodopa or dopamine agonist therapy was present in all patients except two who were untreated at the time of study. Autopsy data are not available. Functional brain imaging studies performed in patients of the Dutch family using dopamine-transporter tracers and SPECT or PET showed severe abnormalities, indicating presynaptic dysfunction of the nigrostriatal dopamine system, the pattern typically observed in Parkinson's disease (PD) (13) .
In comparison with classical, late-onset PD, the clinical phenotype in the Dutch and Italian PARK7-linked families is characterized by an early onset (in the thirties) and a slow disease progression. Furthermore, behavioral and psychic disturbances, and dystonic features (including blepharospasm) have been reported in both families (11, 12) . However, more detailed genotypephenotype correlation studies are needed to accurately define the clinical spectrum associated to mutations in DJ-1 gene.
Fine mapping studies The PARK7 locus as delineated by initial linkage studies (11, 12) spans more than 8 Mb in the current physical map of the Human Genome (NCBI, build 29), including 9 contigs separated by 8 gaps, containing a large number of genes. In the last four NCBI builds of the human genome, released during the course of this study, the order of several contigs inside and in the proximity of the PARK7 region has fluctuated considerably, and for some contigs the internal assembly remains provisional. In order to overcome these difficulties, we have used extensive homozygosity mapping by typing available STR or SNP markers in the two definitely linked families to characterize each of the contigs located inside and flanking the PARK7 genetic borders. Strategy for cloning the deletion breakpoint In order to identify the deletion breakpoint, we designed primer sets to amplify fragments of DNA evenly distributed between the minimal deleted area and the two flanking areas of nondeleted sequence. Iteration of this technique reduced the interval between the deleted region and the flanking, non-deleted borders to less than 3 kb. We then used primers placed on the nondeleted borders to amplify a fragment of about 2000 bp across the deletion breakpoint. In the normal chromosomes, these two primers are separated by about 16 kb.
Replacing the reverse primer with another primer located 250 bases upstream yielded a novel fragment of about 1750 bp in the same individuals, confirming the specificity of the reaction and the presence of the deletion (data not shown).
Cloning of the deletion breakpoint allowed us to test for the presence of the mutation in both heterozygous or homozygous state using PCR.
Relationships between PARK6 and PARK7 A different locus for autosomal recessive early onset parkinsonism (PARK6) has been localized 25 cM centromeric of PARK7 on chromosome 1p35-p36, in a single large pedigree (14) . Given the similarities between PARK6-and PARK7-associated phenotypes, and the proximity of the two loci, it is possible that mutations in similar or functionally-related genes underlie both forms.
As an alternative possibility, a large genomic rearrangement could account for both linkage reports. Linkage analysis of autosomal recessive parkinsonism is complicated by the small size of most recessive pedigrees, presence of further locus heterogeneity, proximity of the two loci on chr.1p. As a result, the assigment of additional smaller families to either PARK6 or PARK7 must be considered as provisional (12, 15) .
Mutation analyses of DJ-1 gene in smaller families and isolated early onset cases Nine additional families with a diagnosis of clinically definite idiopathic parkinsonism in at least two siblings, possible autosomal recessive inheritance (affected sibs, unaffected parents), disease onset before age 50 in at least one sibling, exclusion of linkage to PARK2 locus, or parkin gene mutations excluded by sequencing and exon dosage, were available for analysis. By haplotype analysis, four of these families were compatible with linkage to PARK7; three families to both PARK7 and PARK6; and two families to PARK6 only (16) . None of the abovementioned families could be definitely linked to either of the two loci. Furthermore, twenty-two patients with idiopathic parkinsonism, negative family history and onset below age 40 were also studied. In nine cases mutations in parkin gene had been excluded by genomic sequencing and exon dosage. Sequencing the exons and exon-intron boundaries of the DJ-1 gene in the patients and families described above revealed no pathogenic mutations. Among the same patients and families, there were no carriers of the DJ-1 deletion identified in the Dutch family. However, detection of compound heterozygosity for different genomic rearrangements requires gene dosage analysis which is currently being developed and therefore will be the subject of future studies.
Fig.S1 Mutation analyses

A.
Cosegregation of the genomic deletion in the Dutch family. Duplex PCR from genomic DNA using primers designed to amplify the deletion breakpoint (2011 bp band) and one of the deleted DJ-1 exons (exon 5 -354 bp band). Exon 5 is absent from all patients (hom deletion, lanes 2,3,6,8) ; the deletion breakpoint band is present in homozygous (lanes 2,3,6,8 ) and heterozygous (lanes 4,5,7,9) carriers of the mutant allele (note the dosage effect). Individual 1 is not carrying the disease haplotype, in agreement with data in ref. 11 .
B.
Cosegregation of the L166P mutation in the Italian family. Allele specific oligo hybridization: mut -mutant; wt -wild-type; C -unrelated normal control.
C.
Sequence of the deletion breakpoint in the Dutch family showing the joining of the telomeric and centromeric borders. The breakpoint lies within a 16 bp of sequence identical in the Alus and is depicted in a frame. The specific nucleotides in telomeric and centromeric sequences are indicated by upper lines.
D.
Electropherograms showing the L166P mutation in the Italian family. Sequencing from genomic DNA and cDNA.
E.
Scheme of the genomic rearrangement in the Dutch family.
F.
RT-PCR amplification of a 741 bp fragment corresponding to the DJ-1 cDNA indicates absence of expression in the Dutch patient, and presence of expression in the Italian patient. To exclude the possibility of a polymorphism in one of the primer binding sites this was replicated using six different primer combinations (data not shown). A 285 bp fragment of the KIAA0833 cDNA is amplified as internal PCR control in the left lanes. 
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Fig.S2
Northern blot -different human tissues and brain regions Upper panels: DJ-1 probe. Lower panels: control probe (β-actin). DJ-1 expression is higher in subcortical regions (caudate nucleus, thalamus, s.nigra) than in cortical regions.
Fig.S3
Model of putative DJ-1 function Modification of the DJ-1 protein (by chemical or multimerization changes) may directly buffer cytosolic redox fluctuations; activated DJ-1 may influence expression of genes for oxidative stress response post-transcriptionally (binding to RBP complexes); DJ-1 may also translocate to the nucleus, be sumoylated, and influence gene transcription. 
